Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.258,99
0,38%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IDEAYA Biosciences Inc (IDYA) IDEAYA Biosciences Inc (IDYA) Notizie

IDEAYA Biosciences Inc

IDYA
38,11
-0,82 (-2,11%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/6/202412:05EDGAR2Form 8-K - Current report
03/6/202412:00PRNUSIDEAYA Announces Results for Darovasertib Phase 2 IST in..
31/5/202422:54EDGAR2Form 8-K - Current report
31/5/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
29/5/202423:02EDGAR2Form 144 - Report of proposed sale of securities
29/5/202412:00PRNUSIDEAYA Biosciences to Participate in Upcoming June 2024..
28/5/202412:00PRNUSIDEAYA Biosciences Appoints Daniel A. Simon as Chief..
24/5/202403:21PRNUS/C O R R E C T I O N -- IDEAYA Biosciences, Inc./
23/5/202423:05PRNUSIDEAYA Biosciences Announces Abstract Summary Results of..
07/5/202412:04EDGAR2Form 8-K - Current report
07/5/202412:00PRNUSIDEAYA Biosciences, Inc. Reports First Quarter 2024..
01/5/202412:00PRNUSIDEAYA Biosciences to Participate in Upcoming May 2024..
26/4/202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
24/4/202416:05PRNUSIDEAYA Biosciences Announces ASCO 2024 Oral Presentation for..
22/4/202412:00PRNUSIDEAYA Biosciences Announces Selection of Move-Forward Phase..
05/4/202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
01/4/202412:00PRNUSIDEAYA Biosciences to Participate in Upcoming April 2024..
12/3/202411:00PRNUSIDEAYA Announces Clinical Collaboration to Evaluate IDE161..
04/3/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202412:00PRNUSIDEAYA Biosciences to Participate in Upcoming March 2024..
20/2/202422:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/2/202412:07EDGAR2Form 8-K - Current report
20/2/202412:00PRNUSIDEAYA Biosciences, Inc. Reports Fourth Quarter and..
14/2/202412:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202423:56EDGAR2Form 144 - Report of proposed sale of securities
01/2/202412:00PRNUSIDEAYA Biosciences to Participate in Upcoming February 2024..
26/1/202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
25/1/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202412:03EDGAR2Form 8-K - Current report
19/1/202423:18EDGAR2Form 8-K - Current report
19/1/202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202412:07EDGAR2Form 8-K - Current report
12/1/202422:24EDGAR2Form 144 - Report of proposed sale of securities
12/1/202412:04EDGAR2Form 8-K - Current report
07/1/202415:00PRNUSIDEAYA Biosciences Announces Participation at the 42nd..
29/12/202312:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
27/12/202322:24EDGAR2Form 144 - Report of proposed sale of securities
19/12/202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202301:09EDGAR2Form 144 - Report of proposed sale of securities
15/12/202301:29EDGAR2Form 144 - Report of proposed sale of securities
11/12/202323:45EDGAR2Form 144 - Report of proposed sale of securities
08/12/202312:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
Apertura: 38,41 Min: 37,82 Max: 38,86
Chiusura: 38,93

La tua Cronologia

NASDAQ
IDYA
IDEAYA Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network